P. Riederer

2.3k total citations
68 papers, 1.9k citations indexed

About

P. Riederer is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, P. Riederer has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 16 papers in Neurology and 12 papers in Molecular Biology. Recurrent topics in P. Riederer's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). P. Riederer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). P. Riederer collaborates with scholars based in Germany, Austria and Israel. P. Riederer's co-authors include K. A. Jellinger, Klaus W. Lange, E. Sofić, Johannes Kornhuber, M. Gerlach, Michael Weller, M.B.H. Youdim, Moussa B. H. Youdim, A.X. Trautwein and Luigi Zecca and has published in prestigious journals such as Neurology, Biological Psychiatry and Pain.

In The Last Decade

P. Riederer

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Riederer Germany 19 720 649 512 327 258 68 1.9k
Hideaki Kabuto Japan 22 631 0.9× 438 0.7× 476 0.9× 347 1.1× 195 0.8× 71 2.1k
M.B.H. Youdim Israel 18 654 0.9× 836 1.3× 448 0.9× 304 0.9× 361 1.4× 28 1.8k
W. Gsell Germany 24 438 0.6× 342 0.5× 430 0.8× 443 1.4× 171 0.7× 47 1.5k
Jon‐Son Kuo Taiwan 27 704 1.0× 371 0.6× 615 1.2× 384 1.2× 401 1.6× 78 2.3k
Marti Santiago Spain 25 1.2k 1.6× 547 0.8× 581 1.1× 291 0.9× 352 1.4× 66 2.0k
G. Cohen United States 19 715 1.0× 556 0.9× 764 1.5× 316 1.0× 137 0.5× 37 2.0k
I.A. Paterson Canada 25 1.0k 1.4× 391 0.6× 594 1.2× 125 0.4× 120 0.5× 48 1.8k
Kay Castagnoli United States 28 763 1.1× 845 1.3× 620 1.2× 250 0.8× 169 0.7× 57 2.7k
María A. Mena Spain 31 1.1k 1.5× 1.2k 1.8× 634 1.2× 513 1.6× 351 1.4× 56 2.6k
Alberto Machado Spain 27 814 1.1× 502 0.8× 794 1.6× 383 1.2× 574 2.2× 75 2.3k

Countries citing papers authored by P. Riederer

Since Specialization
Citations

This map shows the geographic impact of P. Riederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Riederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Riederer more than expected).

Fields of papers citing papers by P. Riederer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Riederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Riederer. The network helps show where P. Riederer may publish in the future.

Co-authorship network of co-authors of P. Riederer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Riederer. A scholar is included among the top collaborators of P. Riederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Riederer. P. Riederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Grünblatt, Edna, P. Riederer, Helmut Heinsen, et al.. (2015). Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ. Journal of Neural Transmission. 122(7). 1069–1076. 46 indexed citations
3.
Mößner, Rainald, Ralf Dringen, Antonio M. Persico, et al.. (2002). Increased hippocampal DNA oxidation in serotonin transporter deficient mice. Journal of Neural Transmission. 109(5-6). 557–565. 11 indexed citations
4.
Retz, Wolfgang, Johannes Thome, N. Durany, et al.. (2001). Potential genetic markers of sporadic Alzheimerʼs dementia. Psychiatric Genetics. 11(3). 115–122. 40 indexed citations
5.
Riederer, P., et al.. (1997). Walther Birkmayer — The man behind the name. Journal of Neural Transmission. 104(2-3). V–VIII. 2 indexed citations
6.
Sontag, K.‐H., Christine Heim, Ralf God, et al.. (1995). Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.. PubMed. 46. 283–9. 16 indexed citations
7.
Lesch, Klaus‐Peter, J. Groß, Benjamin Wolozin, et al.. (1994). Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness. Psychiatric Genetics. 4(3). 153–160. 12 indexed citations
8.
Jellinger, K. A., E. Kienzl, Werner Paulus, et al.. (1993). Iron and ferritin in substantia nigra in Parkinson's disease.. PubMed. 60. 267–72. 67 indexed citations
9.
Sofić, E., Klaus W. Lange, K. A. Jellinger, & P. Riederer. (1992). Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neuroscience Letters. 142(2). 128–130. 475 indexed citations
10.
Riederer, P., N. Kopp, & John E. Pearson. (1990). An Introduction to neurotransmission in health and disease. Oxford University Press eBooks. 18 indexed citations
11.
Fritze, J., T. Becker, Vincent E. Ziegler, G. Laux, & P. Riederer. (1990). Brofaromine (CGP 11 305 A) in Treatment of Depression:Biological Estimation of Plasma Concentrations. Pharmacopsychiatry. 23(3). 131–134. 3 indexed citations
12.
Laux, G., T. Becker, G. Kühne, et al.. (1988). Clinical and Biochemical Effects of the Selective Phosphodiesterase Inhibitor Rolipram in Depressed Inpatients Controlled by Determination of Plasma Level. Pharmacopsychiatry. 21(6). 378–379. 11 indexed citations
13.
Birkmayer, W & P. Riederer. (1983). Parkinson’s Disease: Biochemistry, Clinical Pathology, and Treatment. Medical Entomology and Zoology. 23 indexed citations
14.
Riederer, P. & Gavin P. Reynolds. (1981). Determination of a wide range of urinary amine metabolites using a simple high-performance liquid chromatographic technique. Journal of Chromatography B Biomedical Sciences and Applications. 225(1). 179–184. 11 indexed citations
15.
Jellinger, K. A., P. Riederer, & P. Kothbauer. (1979). [The significance of biogenic amines in cerebral infarction (author's transl)].. PubMed. 91(10). 339–44. 2 indexed citations
16.
Jellinger, K. A., P. Riederer, & P. Kothbauer. (1978). Changes of some putative neurotransmitters in human cerebral infarction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31–44. 16 indexed citations
17.
Jellinger, K. A., et al.. (1978). Brain monoamines in hepatic encephalopathy and other types of metabolic coma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 103–20. 16 indexed citations
18.
Riederer, P., et al.. (1978). [Biochemistry of hepatic encephalopathy].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(12). 768–77. 1 indexed citations
19.
Jellinger, K. A. & P. Riederer. (1978). Brain monoamines in metabolic coma and stroke.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20. 535–46. 9 indexed citations
20.
Riederer, P., et al.. (1978). Human cerebral free amino acids in hepatic coma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 95–102. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026